Find clinical trials for Non-Small-Cell Lung Cancer in Houston, TX

This is a phase 3, open-label, 4-cohort study (3 randomized cohorts and 1 single-arm cohort). Participants enrolled in each cohort will be treated as...

This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...

This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...

3-DXd will be evaluated in participants with metastatic or unresectable NSCLC with EGFR activating mutation or squamous or non-squamous NSCL...

is designed to degrade mutant EGFR, which is a common cause for Non-Small Cell Lung Cancer (NSCLC). This...

with separate sub- studies. Sub-study 1 includes participants with non-small cell lung cancer (NSCLC) wi...

N2) NSCLC (per the 8th International Association for the Study of Lung Cancer classification). The primary objective of this study ...

This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small ...

Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mort...

This is a Phase II, multi-center, open-label platform study evaluating novel combination treatment options in participants with locally advanced or m...